Yes. As of September 2026, Immunoprecise Antibodies Ltd (IPA) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Immunoprecise Antibodies Ltd passes Musaffa's business and financial screening criteria.
ImmunoPrecise Antibodies Ltd. is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The company is headquartered in Austin, Texas. The company is advancing Bio-Native AI at the intersection of biology and computation. Its LENSai and HYFT platforms enable large-scale reasoning across sequence, structure, function, and scientific literature, powering workflows across drug discovery, diagnostics, vaccine design, and molecular systems biology. The core of its operations encompasses a diverse suite of proprietary technologies that aid in the exploration, discovery, and development of novel drugs and biologics. Integrated within its wet lab infrastructure is a diverse array of in silico technologies. As an end-to-end service provider of antibody discovery and development, its computational methodologies allow the Company to perform detailed and comprehensive evaluations across various stages of biologic discovery and development. The company is involved in antibody characterization studies, which encompass affinity measurements, epitope landscape profiling, and others.
Immunoprecise Antibodies Ltd IPA
$2.07 $0.14 (7.25%) 1D
Last Updated: Sep 03, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
IPA Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Immunoprecise Antibodies Ltd is classified as halal.
HALAL
Report Source: undefined Quarter Report
Immunoprecise Antibodies Ltd (IPA) Chart
Financial Metrics & Statements of Immunoprecise Antibodies Ltd (IPA)
FAQ's for Immunoprecise Antibodies Ltd (IPA)
As of September 2026, Immunoprecise Antibodies Ltd IPA is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Immunoprecise Antibodies Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Immunoprecise Antibodies Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Immunoprecise Antibodies Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Immunoprecise Antibodies Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Immunoprecise Antibodies Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Immunoprecise Antibodies Ltd (IPA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.